Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Viatris Community
NasdaqGS:VTRS Community
1
Narratives
written by author
0
Comments
on narratives written by author
61
Fair Values set
on narratives written by author
Community Investing Ideas
Viatris
Popular
Undervalued
Overvalued
Viatris
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
New Product Launches And Expense Savings Will Strengthen Future Operations
Key Takeaways New product launches and late-stage developments are expected to drive future revenue growth and improve net margins through higher-margin innovations. Operational expense reviews aim to enhance efficiencies and reduce costs, supporting margin improvements and boosting long-term economic value.
View narrative
US$11.39
FV
11.1% undervalued
intrinsic discount
-0.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
39
users have followed this narrative
20 days ago
author updated this narrative
Your Valuation for
VTRS
VTRS
Viatris
Your Fair Value
US$
Current Price
US$10.12
72.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-3b
17b
2015
2018
2021
2024
2025
2027
2030
Revenue US$14.9b
Earnings US$2.2b
Advanced
Set Fair Value